Cargando…

Effectiveness of Rifaximin on the Outcomes of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder that impacts the lives of many individuals worldwide. We conducted a systemic review and meta-analysis of randomized controlled trials (RCTs) to assess both the effectiveness of rifaximin in alleviating IBS symptoms and its pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Zarghuna, Khan, Saad Khalid, Reyaz, Ibrahim, Anam, Hemalatha, Ijaz, Osama, Attique, Ilqa, Shahzad, Zoha, Saleem, Faraz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558962/ https://www.ncbi.nlm.nih.gov/pubmed/37809182 http://dx.doi.org/10.7759/cureus.44807

Ejemplares similares

Comparing Efficacy and Safety of Different Doses of Tirzepatide for the Treatment of Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
por: Khan, Zarghuna, et al.
Publicado: (2023)

Rifaximin Therapy of Irritable Bowel Syndrome
por: Koo, Hoonmo L., et al.
Publicado: (2012)

A Correlation Between the Pathogenic Processes of Fibromyalgia and Irritable Bowel Syndrome in the Middle-Aged Population: A Systematic Review
por: Valencia, Carla, et al.
Publicado: (2022)

Rifaximin Therapy for Patients With Metronidazole-Unresponsive Clostridium difficile Infection
por: Waqas, Muhammad, et al.
Publicado: (2022)

How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome
por: Vahora, Ilmaben S, et al.
Publicado: (2020)

Fanconi Syndrome in an Adult With Chronic Alcohol Use Disorder: A Rare Etiology
por: Safdar, Shahzad, et al.
Publicado: (2022)

Irritable Bowel Syndrome: Prevalence and Determinants Among Adults in the Makkah Region, Saudi Arabia
por: Hafiz, Tamara A, et al.
Publicado: (2023)

A Comprehensive Review of Transaminitis and Irritable Bowel Syndrome
por: Gadour, Eyad, et al.
Publicado: (2021)

Probiotics in Irritable Bowel Syndrome: A Review Article
por: Sharma, Shatakshi, et al.
Publicado: (2023)

Profile of rifaximin and its potential in the treatment of irritable bowel syndrome
por: Iorio, Natalya, et al.
Publicado: (2015)

Is There a Correlation Between Irritable Bowel Syndrome and Lactose Intolerance?
por: Cancarevic, Ivan, et al.
Publicado: (2020)

Probiotics in Irritable Bowel Syndrome: A Review of Their Therapeutic Role
por: Satish Kumar, Lakshmi, et al.
Publicado: (2022)

Safety and Efficacy of Istaroxime in Patients With Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials
por: Khalid Khan, Saad, et al.
Publicado: (2023)

Red Cell Distribution Width, Mean Platelet Volume, and Neutrophil/Lymphocyte Ratio in Patients With Irritable Bowel Syndrome
por: Kartal, Bahadır, et al.
Publicado: (2023)

A Mexican Honeymoon Marred by Gastrointestinal Upset: A Case of Dientamoeba fragilis Causing Post-infectious Irritable Bowel Syndrome
por: Ali, Saeed, et al.
Publicado: (2017)

Prevalence of Irritable Bowel Syndrome and Frequency of Symptoms in the General Population of Pakistan
por: Bachani, Parkash, et al.
Publicado: (2021)

Migraine and Irritable Bowel Syndrome Among the General Population in Aseer Region
por: Alhammadi, Nouf A, et al.
Publicado: (2023)

Irritable Bowel Syndrome: Treating the Gut and Brain/Mind at the Same Time
por: Jayasinghe, Maleesha, et al.
Publicado: (2023)

Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
por: Lembo, Anthony, et al.
Publicado: (2020)

Methane and Constipation-predominant Irritable Bowel Syndrome: Entwining Pillars of Emerging Neurogastroenterology
por: Bin Waqar, Syed Hamza, et al.
Publicado: (2019)

Irritable Bowel Syndrome: Prevalence and Risk Factors in Jazan Region, Saudi Arabia
por: Arishi, Abdulelah M, et al.
Publicado: (2021)

Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials
por: Li, Jun, et al.
Publicado: (2016)

Prevalence and Symptom Characteristics of Irritable Bowel Syndrome Among Bronchial Asthma Patients in Pakistan
por: Bachani, Parkash, et al.
Publicado: (2020)

High-dose rifaximin treatment alleviates global symptoms of irritable bowel syndrome
por: Jolley, John
Publicado: (2011)

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
por: Boltin, Doron, et al.
Publicado: (2014)

Pharmacological and Non-pharmacological Treatments of Irritable Bowel Syndrome and Their Impact on the Quality of Life: A Literature Review
por: Gendi, Reham, et al.
Publicado: (2020)

The Effectiveness of Polypill for the Prevention of Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials
por: Virk, Ghazala S, et al.
Publicado: (2023)

Small Bowel Obstruction: A Rare Presentation of the Inferior Pancreaticoduodenal Artery Pseudoaneurysm Bleed
por: Zerti, Hasan M, et al.
Publicado: (2021)

A Comparison of the Effects of COVID-19 on Irritable Bowel Syndrome and Inflammatory Bowel Disease Patients While Working at Home and in the Office: A Retrospective Study
por: Zouridis, Spyridon, et al.
Publicado: (2023)

Clozapine Intoxication in a Patient on Chronic Use With a Short-Term Noncompliance
por: Khan, Zoha, et al.
Publicado: (2021)

Association Between Cannabis Use and Healthcare Utilization in Patients With Irritable Bowel Syndrome: A Retrospective Cohort Study
por: Desai, Parth, et al.
Publicado: (2020)

Assessment of Sleep Quality Among Adolescents and Adults With Self-Diagnosed Irritable Bowel Syndrome, in Jeddah, Saudi Arabia
por: Alghamdi, Aisha A, et al.
Publicado: (2023)

Do Socio-Demographics Play a Role in the Prevalence of Red Flags and Pursuant Colonoscopies in Patients With Irritable Bowel Syndrome?
por: Mittal, Anmol, et al.
Publicado: (2022)

Chloroquine-Induced Psychosis: A Case Report
por: Chaudhry, Hamzah E, et al.
Publicado: (2022)

Comparison of the Efficacy and Safety of Aspirin and Low-Molecular-Weight Heparin in Patients With a Fracture: A Meta-Analysis
por: Nimerta, FNU, et al.
Publicado: (2023)

Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile
por: Gupta, Kamesh, et al.
Publicado: (2017)

Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity
por: Pimentel, M., et al.
Publicado: (2017)

Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome
por: Acosta, Andrés, et al.
Publicado: (2016)

Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
por: Rezaie, Ali, et al.
Publicado: (2019)

Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review
por: Chey, William D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ofa8c91ruiqsmtcdjvognb85l